The Indian Medicines Agency has approved the Russian-made Sputnik V coronavirus vaccine as the country grapples with a second wave.
Sputnik V is, after Covishield, developed by Oxford-AstraZeneca and manufactured by the Serum Institute of India, and Covaxin by Indian company Bharat Biotech, the third coronavirus vaccine to be approved for emergency use.
The decision was made by the Drugs Controller General of India after a panel of experts from the Central Drugs Standard Control Organization “considered several critical areas including safety, immunogenicity, efficacy data from overseas clinical trials, indication, age group, dosage schedule, precautions, storage, Warnings, adverse effects of particular concern, risk-benefit assessment… ”the Indian Ministry of Health said in a statement on Tuesday.
Sputnik V, which is approved for use in 60 countries around the world, is manufactured in India by Dr. Reddy’s Laboratories.
In September, the pharmaceutical company partnered with the Russian Direct Investment Fund (RDIF) to conduct clinical trials with Sputnik V and market the vaccine in India. This comes from a press release from Dr. Reddy’s Laboratories.
“We are very happy about the emergency approval for Sputnik V in India. With the increasing number of cases in India, vaccination is the most effective tool in our fight against COVID-19. In this way we can contribute to our country’s efforts to vaccinate a significant part of our population, ”said GV Prasad, Co-Chairman and Managing Director of Dr. Reddy’s Laboratories.
The bigger picture: India reported 161,736 New cases of coronavirus on Tuesday, a slight decline after six consecutive days with record increases in one day, according to a health ministry CNN tally.
The country has recorded overall 13,689,453 Cases that includes 171.058 Deaths and 1,264,698 current cases.
A total of 108,533,085 So far, vaccine doses have been given to health workers and frontline workers as well as to people aged 45 and over.
Several states have announced stricter restrictions to contain the spread of the coronavirus. On Monday, the northern state of Haryana announced a nightly curfew, which is due to come into effect from 9:00 p.m. to 5:00 a.m. until further notice.
The capital city area of Delhi, where 11,491 cases were reported on Monday, is preparing for a surge in cases.
The state government has declared 14 private hospitals in the capital to be “full COVID-19” hospitals and asked them not to admit any patients other than those infected with coronavirus. Nineteen private hospitals have been instructed to reserve at least 80% of their intensive care beds for Covid patients, while another 82 private hospitals have been asked to reserve 60% of their intensive care beds for coronavirus patients Jain.